With the pandemic continuing to disrupt the pharmaceutical industry, drug makers find themselves torn between the traditional domain of drug making and an emerging domain of new platforms and focuses. This disparity was reflected in the most popular pieces of content from Pharmaceutical Processing World in 2021. 1. GSK, Pfizer and J&J among the most-fined drug…